This two-day workshop will explore whether, how, and which advances in clinical proteomics can be translated into meaningful applications in clinical practice. Bringing together perspectives from epidemiology, proteomic discovery, clinical research, laboratory medicine, health economics and implementation disciplines, the programme will examine the scientific opportunities and practical implementation challenges of clinical translation.

The first day consists of three sessions:

The opening session, “Proteomic Discovery in Large-Scale Studies”, will focus on recent developments in high-throughput proteomics, as well as the opportunities arising from large-scale studies and precision medicine.

“Economic, Legal and Implementation Aspects of Proteomics” will address the broader requirements for the clinical application of proteomic technologies, including economic, regulatory, legal and implementation considerations.

The final session, “Clinical Transition of Proteomics Technologies”, will focus specifically on the challenges of integrating proteomics technologies into clinical settings, and the factors that need to be considered for successful implementation.

The scientific session combines panel discussions and interactive breakout sessions, allowing participants to critically discuss the topics from different disciplinary perspectives and identify common challenges, opportunities and priorities.

On the second day, the focus will be on the participants and their perspectives. Selected participants will give short presentations on their work, after which there will be a discussion and a dedicated breakout session. These contributions will then inform a moderated discussion session, which will bring together the key themes that emerge throughout the workshop. The workshop will conclude with a summary of the discussion, capturing the main points raised, shared priorities, and potential directions for the field over the next five years.

The programme is designed to encourage participants to form interdisciplinary connections and develop collaborations that could contribute to the future translation of proteomics into clinical practice. This will be achieved by offering ample networking and informal exchange opportunities throughout the programme, including a poster presentation and a networking dinner.

The full preliminary programme can be viewed in the box on the right. Please note that the programme starts early on 3 March, so please keep this in mind when planning your travel if you live outside of the Copenhagen metropolitan area. You can find more information about accommodation and other practical details under “Details.”

Confirmed speakers:

• Benedikt Kessler, Professor, University of Oxford (UK)
• Claudia Langenberg, Director, Professor, Precision Healthcare University Research Institute, Quenn Mary University of London (UK)
• Harald Mischak, Professor, Executive Director, Co-founder, University of Glasgow, Mosaiques diagnostics GmbH (UK)
• Jochen Schwenk, Professor, Head of Division, Platform Scientific Director, Biomedical Proteomics, KTH Royal Institute of Technology and SciLifeLab (SE)
• Karl Smith-Byrne, Associate Professor, Senior Molecular Epidemiologist, University of Oxford (UK)
• Mattias Johansson, Scientist, International Agency for Research on Cancer, World Health Organization (FR)
• Valborg Guðmundsdóttir, Research Associate Professor, University of Iceland & The Icelandic Heart Association (IS)

Organisers:
This event is organised by the Danish Diabetes and Endocrine Academy (DDEA) in collaboration with the scientific organising committee consisting of:

• Thilo Chillon, Postdoctoral Fellow, Odense University Hospital (DK)
•  Kamil Demircan, Postdoctoral Fellow, Queen Mary University of London (UK)
• Julia Carrasco Zanini Sanchez, Lecturer, Queen Mary University of London (UK)
• Martin Overgaard, Associate Professor, Odense University Hospital (DK)
• Nils Færgeman, Professor, University of Southern Denmark (DK)

This workshop is intended for early career researchers working within clinical proteomics or its translation into clinical practice, spanning epidemiology, laboratory medicine and clinical biochemistry, clinical specialties such as diabetology, endocrinology and cardiology, wet lab science and pre-analytics, pharma and biotech, health economics, and implementation science. Senior scientists and established experts are also welcome to apply.

We expect participants to have relevant experience or expertise in proteomics; however, if you are a clinical participant, you are not required to have specific proteomics expertise, as we value your perspective on clinical relevance, implementation and patient care as an essential part of the workshop.

Researchers at institutions within Denmark and abroad are welcome to apply.

Participants are selected based on their submitted abstract and motivational statement (see the guidelines under “Abstract Submission”). After the registration deadline, all applicants will be informed whether or not they have been allocated a seat at the workshop. Notification will be by email from DDEA.

Please note that you are not guaranteed a seat at the workshop if you do not meet the target group requirements. If the event is overbooked, DDEA reserves its right to select participants based on the defined requirements.

Dinner registration:
A networking dinner is part of the workshop programme. Participation in the dinner is free of charge. Please confirm your participation in the dinner on 3 March upon registration, and indicate whether you have any dietary requirements.

Accommodation:
DDEA offers 1-night accommodation for participants from outside of the Copenhagen metropolitan area. Check-in on 3 March and check-out on 4 March 2027.

Please sign up for accommodation when you register for the event. You will be informed about your overnight accommodation by the DDEA after the registration deadline.

Please note that the event starts early on 3 March, and participants are expected to be present from the beginning of the programme. If your travel requires you to arrive in Copenhagen the day before, you will need to arrange and cover any additional accommodation yourself. Please feel free to contact DDEA if you need information about hotel options in Copenhagen.

Certificate of Attendance:
A course certificate of attendance and participation can be issued upon request at the end of the course.

Latest cancellation date & no-show fee:
Please note that it is free of charge to participate in the event however the DDEA will charge a no-show fee of 1000 DKK if you do not show up and have not unregistered from the event by 11 February 2027.

Deadline for submission of abstracts: 24 January 2027

Abstract guidelines:
Be sure your abstract contains the following information and adheres to the following formatting guidelines before submission:
You may download the template here

The abstract should be max 1500 characters incl. spaces and written in Arial 10.

• Title of abstract (Use a short and specific title with title-style capitalization and put it in bold)
• Presenting author name(s) (Underline the presenting author’s name)
• Affiliation (Include unit, institution/company/hospital, city and country for all authors and put it in italic)

The body of the abstract contains the following content: background and aim, rationale, methods, results (if obtained to-date), conclusion (and perspectives)
(Text in Arial 10)
No images, figures, charts or tables should be included in the abstract.
Please proofread carefully before submission and submit a Word file and please name the file that you submit with your name.

Format of poster:
Size of poster: A0 or A1 – width max. 1 m/height max. 1.25 m (“Portrait format” is visually preferred)

Motivational statement guidelines:
Please write your motivational statement directly in the designated text box in the registration form when you sign up for the workshop. Your statement should address the following three questions:

• Why do you want to participate in this workshop, and what do you hope to gain from it?
  Please describe your motivation for participating and explain how the workshop relates to your current research, career development, or professional interests.

• How are you involved in clinical proteomics in your current research or professional environment?
  Please briefly describe your role, experience, and/or connection to clinical proteomics, including how your work relates to its development, application, or translation into clinical practice.

• What do you see as the key challenges and opportunities for clinical proteomics over the next five years, and what perspective or expertise would you contribute to the discussion?
  Please highlight the developments you consider most important for translating proteomics into clinical practice and explain what you could contribute to the workshop discussions and the development of a shared roadmap for the field.